브리짓라이프사이언스

This profile gathers the share dealings of 브리짓라이프사이언스 in 엔지켐생명과학, where the filings describe the role as chief executive. Over a trading history stretching from 2 December 2021 to 15 October 2026, the count stands at 44 filings.

Both buying and selling appear: 4 purchases worth €645k, against 1 sale. The totals exclude 3 filings filed without an amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Since January 2026: 3 purchases and 1 sale on the market.

2 out of 4 purchases came within 30 days of a purchase by at least one other insider of the same company. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

The latest filing, published on 15 October 2026, reports a transaction in 엔지켐생명과학. The most recent open-market purchase was published on 8 May 2026, 163 days ago. Filings reach the DART (FSS) feed a median of 7 days after the trade. Until a filing is published, the market cannot know about the trade. Source: insider filings from DART (FSS). Past trades are no guide to future returns.